It has been proposed that Complex Regional Pain Syndrome (CRPS) is a post-traumatic autoimmune disease and we previously observed that B cells are required for the full expression of CRPS-like changes a mouse tibia fracture CRPS model. The current study used the mouse model to evaluate the progression of post-fracture CRPS-like changes in wildtype (WT) and muMT fracture mice lacking B cells and antibodies. The pronociceptive effects of injecting WT fracture mouse serum antibodies into muMT fracture mice were also evaluated. Post-fracture pain behaviors transitioned from being initially dependent on both innate and autoimmune inflammatory mechanisms at 3 weeks post-fracture to being entirely mediated by antibody responses at 12 weeks post-fracture and spontaneously resolving by 21 weeks post-fracture. Furthermore, serum IgM antibodies from WT fracture mice had pronociceptive effects in the fracture limb when injected into muMT fracture mice. IgM antibody levels gradually increased in the fracture limb hindpaw skin, sciatic nerve, and corresponding lumbar cord, peaking at 12–18 weeks post-fracture and then declining. Immunohistochemistry localized post-fracture IgM antibody binding to antigens in the fracture limb hindpaw dermal cell nuclei. We postulate that fracture induces expression of neoantigens in fracture limb skin, sciatic nerve, and cord, which trigger B cells to secret IgM antibodies that bind those antigens and initiate a pronociceptive antibody response. Autoimmunity plays a key role in the progression of nociceptive and vascular changes in the mouse fracture model and potentially contributors to the CRPS disease process.